Genetic study questions wine’s cardiovascular benefits

Angela Marshall | | Cardiovascular Business | Patient Care

A glass of wine may not be as heart-smart as previously believed. An international research team looking at a gene variant that reduced alcohol consumption found that in those people who consumed less alcohol, markers for cardiovascular disease were also reduced.

Published online July 10 in BMJ, the analysis assessed 56 studies where participants had been found to have the ADH1B rs1229984 A-allele. This genotype was not associated with reduced risks for cardiovascular disease itself; it instead, controls metabolism and consumption of alcohol. Those with the rs1229984 A-allele show reduced interest in alcohol consumption and lower risk of alcoholism.

In those carrying this genetic marker, researchers found lower inflammatory biomarkers, blood pressure and cholesterol, bringing the protective nature of alcohol in heart disease into question.

Michael V. Holmes, MD, PhD, of the University College London in the U.K., and colleagues noted that the rs1229984 A-allele group consumed 17.2 percent fewer units of alcohol per week. The group also had 5.2 percent lower levels of interleukin-6. C reactive protein levels were 3.4 percent less in this group and odds of hypertension in the rs1229984 A-allele group were 0.94 on average.

Holmes et al noted, however, that the rs1229984 A-allele group had higher triglycerides on average, but they were unable to associate that finding with either the amount of alcohol consumed or the activity of the gene.

When drinkers were subdivided into light, moderate and heavy, they noticed no difference between the rs1229984 A-allele carriers and noncarriers in risk. They were unable to associate rs1229984 A-allele with stroke risks, coagulation markers or markers for diabetes.

Further studies are needed to confirm whether rs1229984 A-allele itself or level of alcohol consumption had the greatest benefit. The research team recommended reduction in alcohol consumption, regardless of genetic profile or number of drinks consumed per week for cardiovascular health.

Angela Marshall

Related Content

Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care
Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes
FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."